Shares of Health Insurance Innovations, Inc. (NASDAQ:HIIQ) were down 1.3% during mid-day trading on Friday following insider selling activity. The company traded as low as $30.00 and last traded at $30.00. Approximately 388,852 shares traded hands during trading, a decline of 26% from the average daily volume of 526,202 shares. The stock had previously closed at $30.40.

Specifically, insider Sheldon Wang sold 5,149 shares of the firm’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $21.60, for a total value of $111,218.40. Following the transaction, the insider now directly owns 228,751 shares of the company’s stock, valued at $4,941,021.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Michael D. Hershberger sold 5,000 shares of the firm’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $23.22, for a total value of $116,100.00. Following the completion of the transaction, the chief financial officer now directly owns 105,369 shares in the company, valued at $2,446,668.18. The disclosure for this sale can be found here. Insiders sold 238,288 shares of company stock worth $6,523,892 over the last three months. Insiders own 30.00% of the company’s stock.

A number of research analysts have recently weighed in on the company. Zacks Investment Research raised Health Insurance Innovations from a “hold” rating to a “strong-buy” rating and set a $27.00 price objective on the stock in a research report on Wednesday, June 21st. Craig Hallum assumed coverage on Health Insurance Innovations in a research report on Monday, June 12th. They set a “buy” rating and a $28.00 price objective on the stock. Canaccord Genuity reaffirmed a “buy” rating and set a $39.00 price objective (up from $30.00) on shares of Health Insurance Innovations in a research report on Friday, August 4th. Finally, ValuEngine cut Health Insurance Innovations from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Health Insurance Innovations has an average rating of “Buy” and a consensus target price of $31.33.

The company has a market cap of $373.45 million, a PE ratio of 24.23 and a beta of 0.65. The firm’s 50-day moving average price is $31.49 and its 200-day moving average price is $22.59.

Health Insurance Innovations (NASDAQ:HIIQ) last issued its earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.13. The firm had revenue of $61.80 million for the quarter, compared to the consensus estimate of $53.69 million. Health Insurance Innovations had a return on equity of 22.89% and a net margin of 5.56%. The company’s revenue was up 38.9% compared to the same quarter last year. Equities analysts predict that Health Insurance Innovations, Inc. will post $1.53 earnings per share for the current year.

A number of hedge funds have recently modified their holdings of HIIQ. Bank of Montreal Can purchased a new position in Health Insurance Innovations during the first quarter worth approximately $118,000. Bank of New York Mellon Corp boosted its position in Health Insurance Innovations by 11.5% during the first quarter. Bank of New York Mellon Corp now owns 12,270 shares of the financial services provider’s stock worth $197,000 after purchasing an additional 1,266 shares in the last quarter. Airain ltd purchased a new position in Health Insurance Innovations during the first quarter worth approximately $537,000. Millrace Asset Group Inc. purchased a new position in Health Insurance Innovations during the first quarter worth approximately $1,840,000. Finally, SG Americas Securities LLC purchased a new position in Health Insurance Innovations during the first quarter worth approximately $252,000. Institutional investors own 90.32% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Health Insurance Innovations, Inc. (HIIQ) Shares Down 1.3% After Insider Selling” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/08/health-insurance-innovations-inc-hiiq-shares-down-1-3-after-insider-selling.html.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Receive News & Stock Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related stocks with our FREE daily email newsletter.